Fig. 4From: Reverse pharmacophore mapping and molecular docking studies for discovery of GTPase HRas as promising drug target for bis-pyrimidine derivativesHEK-293 kidney cells toxicity analysis of most active anti-carcinogenic compounds at different concentration of eachBack to article page